Insider Transactions in Q4 2023 at Day One Biopharmaceuticals, Inc. (DAWN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2023
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,313
-31.74%
|
$58,443
$11.69 P/Share
|
|
Nov 16
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
956
-0.35%
|
$10,516
$11.69 P/Share
|
|
Nov 16
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
709
-0.06%
|
$7,799
$11.69 P/Share
|
|
Nov 16
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,107
-0.44%
|
$34,177
$11.69 P/Share
|
|
Nov 15
2023
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+26.81%
|
-
|
|
Nov 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.67%
|
-
|
|
Nov 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
Nov 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.58%
|
-
|
|
Oct 20
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
111,387
+0.85%
|
$1,002,483
$9.97 P/Share
|
|
Oct 19
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
384,400
+2.91%
|
$3,844,000
$10.06 P/Share
|
|
Oct 18
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
979,667
+7.3%
|
$9,796,670
$10.21 P/Share
|